Ionis Pharmaceuticals, Inc. Common Stock (IONS) is a publicly traded Healthcare sector company. As of October 15, 2026, IONS trades at $44.05 with a market cap of $7.04B and a P/E ratio of -18.23. IONS moved +3.19% today. Year to date, IONS is -46.40%; over the trailing twelve months it is -40.17%. Its 52-week range spans $23.95 to $86.74. Analyst consensus is strong buy with an average price target of $84.00. Rallies surfaces IONS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for IONS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $44.05 |
| Market Cap | $7.04B |
| P/E Ratio | -18.23 |
| EPS | $-2.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $86.74 |
| 52-Week Low | $23.95 |
| Volume | 829.29K |
| Avg Volume | 0 |
| Revenue (TTM) | $943.71M |
| Net Income | $-381.39M |
| Gross Margin | 98.31% |
21 analysts cover IONS: 0 strong buy, 17 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $84.00.